PI 3-Kinase p85 beta Antibody [PerCP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-99487PCP
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Bovine (100%), Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Immunohistochemistry-Paraffin
Label
PerCP (Excitation = 490 nm, Emission = 675 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for PI 3-Kinase p85 beta Antibody [PerCP]
Immunogen
Produced in rabbits immunized with a synthetic peptide corresponding to the center region of the Human PI 3-Kinase p85 beta.
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for PI 3-Kinase p85 beta Antibody [PerCP]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen and protein A Affinity-purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: PI 3-Kinase p85 beta
Long Name
Phosphatidylinositol-3-kinase 85 kDa Regulatory Subunit beta
Alternate Names
p85-beta, PI 3Kinase p85 beta, PIK3R2
Gene Symbol
PIK3R2
Additional PI 3-Kinase p85 beta Products
Product Documents for PI 3-Kinase p85 beta Antibody [PerCP]
Product Specific Notices for PI 3-Kinase p85 beta Antibody [PerCP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...